GUANGJI PHARMA: 2'-Fucosyllactose Approved
GUANGJI PHARMA announced that the administrative license application for 2'-fucosyllactose submitted by the company has passed the review by the National Health Commission and has been announced. 2'-FL is a oligosaccharide that is abundant in breast milk and has various functions. The approval of 2'-FL by GUANGJI PHARMA and the acquisition of a new variety license for food additives represent an important advancement in the company's synthetic biology application field. However, the future production, market acceptance, sales situation, and performance may still be affected by uncertainties such as changes in market demand and adjustments in policies and regulations
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments